With respect to the clinical trial mentioned in the article, which is due to commence at the Royal Adelaide Hospital, details are available on ANZCTR….
This will be a 5 person trial involving participants ranging from those with life-threatening burn injuries, up to and including those meeting the criteria for non-survivable burn injury (Full-thickness burn injuries between 30% and 100% Total Body Surface Area).
The scientific title of the study is
A prospective evaluation of Cultured Composite Skin (CCS) as a definitive closure second stage [where biodegradable polyurethane dermal matrix (BTM) represents the first stage] in the management of extensive deep burn injury.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376542&isReview=true
DR Greenwood CCS 1st patient, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
-0.010(0.49%) |
Mkt cap ! $1.409B | |||
| Open | High | Low | Value | Volume |
| $2.07 | $2.08 | $2.03 | $685.4K | 334.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 13676 | $2.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.05 | 8861 | 19 |
View Market Depth
| Last trade - 13.06pm 12/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |